京é½å¤§å¦(京大)ã¯4æ11æ¥ãæ«æ¢¢è¡ä¸ã«æ°%ããåå¨ããªã好塩åºçã¨å¥½é ¸çãç¸äºä½ç¨ãããã¨ã§ãããã¤ãã¶ã(åºæ¿æ§ç®èç)ãå¼ãèµ·ãããã¨ãæããã«ããã¨çºè¡¨ããã åææã¯ãå大 å»å¦ç 究ç§ã®å®®å°è¯æ¨¹ ææãå æ¤å³¶å¥æ²» åææãå ä¸å¶åç´ å©æãå 大å¡ç¯¤å¸ é常å¤è¬å¸«(ãã¥ã¼ãªãã大å¦ç é¢ç®èç§ç 究å¡)ãã«ãããã®ã詳細ã¯ç±³å½ç§å¦èªãThe Journal of Allergy and Clinical Immunologyãã«æ²è¼ãããã å¥½é ¸çã¯ãæ«æ¢¢è¡ä¸ã®2ï½5%ãå ããé¡ç²çã§ãããã¾ã§ã®ç 究ãããã¢ã¬ã«ã®ã¼æ§ç¾æ£ããã³å¯çè«ç¾æ£ã«é¢ä¸ãã¦ãããã¨ãå ±åããã¦ãããä¸æ¹ã®å¥½å¡©åºçã¯ãæ«æ¢¢è¡ä¸ã«ç´0.5%ã®ã¿åå¨ããé¡ç²çã§ãç 究ã°ã«ã¼ãã®ããã¾ã§ã®èª¿æ»ã§ã好塩åºçãã¢ããã¼æ§ç®èçã®ä¸»ä½ã¨ãªãTh2åå¿ã«éè¦ãªåãããã¦ãããã¨ãå¤æãã¦ãããããããããã¤ãã¶ããªã©ã®åº
ç´3å¹´éã«ããã£ã¦ãã身è¿ãªæ©ã¿ã解決ãã主婦ã®å³æ¹ããæ²ããã³ã³ãã³ããé ä¿¡ãã¦ãã¾ãããWooRisãã¯ã10æ2æ¥ããã£ã¦ãè¨äºã®æ´æ°ãåæ¢ãããµã¼ãã¹ãçµäºããã¦ããã ããã¨ã«ãªãã¾ããã é·ãã«ããã£ã¦ãæèªããã ãã¾ããã¦ã¼ã¶ã¼ã®çæ§ãèª ã«ãããã¨ããããã¾ããã WooRisç·¨éé¨ ãç¥ãã 2017å¹´10æ4æ¥ããã主婦ã«åãã¦æ å ±çºä¿¡ããã¦ãããWooRisãã¨ãå§å¦¹ãµã¤ããBizLadyããã³ã³ã»ãããçµ±åããæ°ã¡ãã£ã¢ãkufuraï¼ã¯ãã©ï¼ããã¹ã¿ã¼ããã¾ãã ãkufuraãã¯ãä»äºã¨å®¶åºã両ç«ãã女æ§ã«åããã¡ãã£ã¢ã§ããæ¯æ¥ã®çæ´»ã«å½¹ç«ã¤æ å ±ãè¨äºãåç»ã§é ä¿¡ãã¦ãã¾ãã kufuraã®Webãµã¤ãã¯ã³ãã©
by ã©ã¤ããã¢ãã¥ã¼ã¹ç·¨éé¨ ãã£ããè¨ã㨠ããã¼ãããµã¼ã¸ã®æ³¨æç¹ãç´¹ä»ãã¦ãã æã®ã²ãå ¨ä½ã§è§¦ãããã¨ã«ããã温ãããå®å¿æã赤ã¡ããã«ãããã ãªã¤ã«ã¯ãé£ã¹ã¦ãå®å¿ãªæ¤ç©æ²¹ã使ããã¨ãéè¦ã§ãã æä¾ç¤¾ã®é½åã«ãããåé¤ããã¾ããã æ¦è¦ã®ã¿æ²è¼ãã¦ããã¾ãã é¢é£ãã¥ã¼ã¹ ã©ã³ãã³ã° ç·å å½å æ¿æ²» æµ·å¤ çµæ¸ IT ã¹ãã¼ã è¸è½ 女å
ãã®ãã¡ã¤ã³ã¯ ãåå.com ããåå¾ããã¾ããã ãåå.com 㯠GMOã¤ã³ã¿ã¼ãããã°ã«ã¼ã(æ ª) ãéå¶ããå½å ã·ã§ã¢No.1ã®ãã¡ã¤ã³ç»é²ãµã¼ãã¹ã§ãã â»è¡¨ç¤ºä¾¡æ ¼ã¯ãå ¨ã¦ç¨è¾¼ã§ãã â»ãµã¼ãã¹å質ç¶æã®ãããä¸æçã«å¯¾è±¡ã¨ãªãæéã¸ä¸å®å²åã®ããµã¼ãã¹ç¶æ調æ´è²»ããå ç®ããã¦ããã ãã¾ãã â»1 ãå½å ã·ã§ã¢ãã¯ãICANN(ã¤ã³ã¿ã¼ãããã®ãã¡ã¤ã³åãªã©ã®è³æºã管çããéå¶å©å£ä½)ã®å ¬è¡¨æ°å¤ããã¨ã«éè¨ãgTLDãéè¨ã®å¯¾è±¡ã æ¥æ¬ã®ãã¡ã¤ã³ç»é²æ¥è (ã¬ã¸ã¹ãã©)ï¼ãICANNãã¬ã¸ã¹ãã©ã¨ãã¦èªå®ããä¼æ¥ãä¸è¦§ï¼InterNICæä¾ï¼å ã«ãJapanãã®è¨è¼ããããã®ï¼ã対象ã ã¬ã¸ã¹ãã©ãGMO Internet Group, Inc. d/b/a Onamae.comãã®ã·ã§ã¢å¤ãéè¨ã 2024å¹´5ææç¹ã®èª¿æ»ã
æ¥æ¬å°å ã¢ã¬ã«ã®ã¼å¦ä¼ã¯ãåã©ãã®æ°ç®¡æ¯ããããã®æ²»çã§åºã使ããã¦ããå¸å ¥ã¹ããã¤ãè¬ããããæ éã«ä½¿ããã注æåèµ·ãã声æãåºãããå¯ä½ç¨ã§åã©ãã®èº«é·ã®ä¼¸ã³ãæããå¯è½æ§ããæµ·å¤ã§å ±åãããããã ããã ãæ²»çã®å¹æã¯å¤§ãããããç ç¶ããã¾ãã«èª¿ã¹ã¦ã使ãã®ã¯å¿ è¦æå°éã«ãããã¨ãæ±ãã¦ããããï¼ï¼æ³ä»¥ä¸ã®å°å ããããã¯ãï¼ï¼äººã«ï¼äººç¨åº¦ããã¨ããã¦ãããçºçããã®ã¯ï¼ï½ï¼æ³ã®ä¹³å¹¼å ãå¤ãããããªã©ã¸ã®ã¢ã¬ã«ã®ã¼åå¿ã§æ°ç®¡æ¯ã«ççãèµ·ããã®ãåå ã ãçºä½ãæ²»ã¾ã£ãå¾ãççãç¶ããããçºä½ã®é²æ¢ã«ã¯æ²»çãé·æéç¶ããå¿ è¦ããããããã使ãããã®ãå¸å ¥ã¿ã¤ãã®ã¹ããã¤ãè¬ãããããåã©ãã®èº«é·ã®ä¼¸ã³ãæå¶ããããã®å½±é¿ã¯æ人ããå¾ãç¶ãã¨ããå ±åããï¼å¹´ã»ã©åããç±³å½ã§ç¸æ¬¡ãã ãæ£è ç´ï¼ï¼ï¼äººã®èª¿æ»ã§ã¯ãï¼ï½ï¼ï¼æ³ããå¸å ¥ã¹ããã¤ãæ²»çãï¼ï½ï¼å¹´éåããæ£è ã¯ããã®è¬ã使ããªãã£ãæ£è ã¨æ¯
ã©ã³ãã³ã°
ã©ã³ãã³ã°
ã©ã³ãã³ã°
ãªãªã¼ã¹ãé害æ å ±ãªã©ã®ãµã¼ãã¹ã®ãç¥ãã
ææ°ã®äººæ°ã¨ã³ããªã¼ã®é ä¿¡
å¦çãå®è¡ä¸ã§ã
j次ã®ããã¯ãã¼ã¯
kåã®ããã¯ãã¼ã¯
lãã¨ã§èªã
eã³ã¡ã³ãä¸è¦§ãéã
oãã¼ã¸ãéã
{{#tags}}- {{label}}
{{/tags}}